Abstract
A method involving high performance liquid chromatography with tandem mass spectrometric detection was developed to determine the concentration of a new macrolide derivative, ABT-229, in human plasma. The analyte was extracted using liquid-liquid extraction with a mixture of ethyl acetate and hexane at basic pH. Detection was highly specific for the analyte of interest, as evidenced by the lack of interference in the chromatograms of drug-free plasma extracts. The lower limit of quantitation was 0.10 ng/mL based on 1 mL of extracted plasma. The linear calibration range of the procedure extended from 0.10 to 199 ng/mL. The method proved reliable and rugged; within-run and day-to-day relative standard deviations were less than 10%. The stability of ABT-229 under frozen storage, room temperature, and freeze/thaw conditions was found to be excellent. Plasma concentrations determined by the method were highly comparable with data obtained by electrochemical detection.
ACKNOWLEDGMENT
The authors gratefully acknowledge Gaynelle E. Stamm for her contributions to the overall project.